PSMA-RADS-3D lesions do not have radiotracer uptake, but anatomic imaging raises suspicion of malignancy, e.g., a neuroendocrine PCa with obvious sites of metastatic disease on CT but no associated PSMA-targeted radiotracer uptake. The gene discussed is FOLH1; the disease is metastatic neoplasm.